Clinical Trial

STReetlab Assessment Tool of Activities Daily Living in Glaucoma Patient

Study acronym: STRATAL-GL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The impact of glaucomatous optic neuropathy on the daily life of patients is poorly characterized and does not benefit from standardized tests. The development and validation of new tests could be used to assess the efficacy of innovative treatments for visually impaired patients and/or optimize management strategies.
Trial Details
NCT Number NCT05747781
Lead Sponsor Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Conditions Optic Neuropathy
Enrollment 100 participants
Start Date 2023-03-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2023-02-28